Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

107.61
+0.61000.57%
Volume:566.69K
Turnover:60.77M
Market Cap:12.21B
PE:31.82
High:108.17
Open:107.96
Low:106.34
Close:107.00
52wk High:111.15
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:0.42
T/O Rate:0.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:85.09
PE(LYR):42.04

Loading ...

Halozyme Partners with Incyte on Enhanze Subcutaneous Formulation for Inca033989 Antibody

Reuters
·
Jul 20

Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of Inca033989 Using Its Enhanze® Technology

THOMSON REUTERS
·
Jul 20

Halozyme Therapeutics - Eligible to Receive Royalties on Net Sales of Enhanze Medicines

THOMSON REUTERS
·
Jul 20

Halozyme Therapeutics - to Receive Upfront Payment and Eligible for Milestone Payments from Incyte

THOMSON REUTERS
·
Jul 20

Halozyme Therapeutics - Incyte Granted Rights to Develop Enhanze with Mutcalr Program and Option for Two Additional Targets

THOMSON REUTERS
·
Jul 20

China's High-Barrier "HALO Assets" Offer Global Scarcity, Says Morgan Stanley Economist

Deep News
·
Jul 17

Halozyme CEO Helen Torley Disposes of 1,923 Common Shares Worth $146,852.55

Reuters
·
Jul 10

Goldman Sachs Revives "HALO Trade" Concept, Signaling a New Phase

Deep News
·
Jul 08

Halozyme Appoints David Ramsay as President Drug Delivery

Reuters
·
Jul 06

Stocks to Watch: Seer, Orthofix Medical, Halozyme Therapeutics

Dow Jones
·
Jul 03

Halozyme Director Bernadette Connaughton Sells 1,625 Shares Worth $124,370.63

Reuters
·
Jul 03

Halozyme Therapeutics Operating Chief Caudill to Exit

Dow Jones
·
Jul 03

Halozyme COO Cortney Caudill Departs Amid Senior Management Restructure

Reuters
·
Jul 03

Halozyme Director Mahesh Krishnan Disposes of 7,304 Shares for $547,800

Reuters
·
Jul 01

Halozyme Names David Ramsay President of Drug Delivery Unit

Reuters
·
Jul 01

Halozyme Appoints David Ramsay as President Drug Delivery

THOMSON REUTERS
·
Jul 01

LifeMD partners with Halozyme unit Antares to launch XYOSTED telehealth self-pay program in July 2026

Reuters
·
Jun 22

Halozyme Therapeutics Expects Proposed Rule to Have Little Impact on Royalties

MT Newswires Live
·
Jun 15

Analysts Conflicted on These Healthcare Names: Incyte (INCY), Intellia Therapeutics (NTLA) and Halozyme (HALO)

TIPRANKS
·
Jun 15

Halozyme sees zero to minimal royalty hit through at least 2035 under draft Medicare drug pricing rule

Reuters
·
Jun 15